5d 1m 3m 1y 5y 10y
There are no Transcripts on AERI.
Business Wire (Wed, 7:30AM)
Business Wire (Feb 27, 2014)
Aerie Pharmaceuticals Names Marvin J. Garrett as Vice President, Regulatory Affairs and Quality AssuranceBusiness Wire (Feb 24, 2014)
Business Wire (Feb 19, 2014)
Aerie Pharmaceuticals Reports Positive Results for Lead Candidate AR-13324 in Normotensive IndividualsBusiness Wire (Jan 9, 2014)
AERI vs. ETF Alternatives
Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.